LogicBio Therapeutics logo
LogicBio Therapeutics LOGC
report update icon

Quarterly report 2022-Q3
added 05-16-2026

LogicBio Therapeutics Long Term Debt Current | LOGC

Annual Long Term Debt Current LogicBio Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.23 M 1.09 M 504 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.23 M 504 K 942 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Annexon Annexon
ANNX
2.91 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
1.73 M - - $ 1.83 B belgiumBelgium
Achieve Life Sciences Achieve Life Sciences
ACHV
61 K $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
38 K - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
282 K - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
1.87 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
1.59 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
825 K - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
14.9 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
2.15 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
234 K - -23.04 % $ 26.6 M usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
1.12 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
3.81 K - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
338 K - - $ 109 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
4.1 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
445 K - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
67 K - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
19 K - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
9 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
1.11 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
336 K - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
1.4 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
25.1 M - - $ 546 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
868 K - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
671 K - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
4.48 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
781 K - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
5.38 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
6.49 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
102 M $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
569 K $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
3.63 M - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
234 K - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
21.8 M - - $ 58.1 M usaUSA